Speaker

Rachel Knopp

Lead iPSC Characterisation team, Astellas Pharma

Rachel Knopp, Lead iPSC Characterisation team at Astellas Pharma, spoke at 6th iPSC Drug Development Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Implementing Robust Cell‑Based Characterization Strategies to De‑Risk Gene Edited iPSC Manufacturing”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

6th iPSC Drug Development Summit
9–10 Sept 2026Boston, United States of America
- SpeakerImplementing Robust Cell‑Based Characterization Strategies to De‑Risk Gene Edited iPSC Manufacturing

More speakers at 6th iPSC Drug Development Summit

Damien Zanker
Clinical Manufacturing Head, Cartherics Pty Ltd
Yasunori Aizawa
Chief Scientific Officer, Logomix, Inc.
Seongho Bae
Head of Research & Development, Karis Bio
Stefan Braam
President & Chief Technology Officer, Cellistic
Matthew Buckley
Chief Executive Officer & Co-Founder, Theseus Therapies
Frederic Cedrone
Vice President, Corporate Innovation, Catalent, Inc.

See all 32 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Rachel Knopp, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].